Safety and Immunogenicity Among Healthy Children Receiving Fluzone Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Phase of Trial: Phase IV
Latest Information Update: 26 Oct 2015
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors sanofi pasteur
- 16 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Sep 2014 Trial status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Aug 2014 New trial record